CytoDyn Inc. total revenue, net income and dynamics of changes in US dollar today
Net income of CytoDyn Inc. today amounted to -43 985 000 $. The dynamics of CytoDyn Inc. net income fell by -9 019 000 $ for the last reporting period. These are the main financial indicators of CytoDyn Inc.. The financial graph of CytoDyn Inc. displays the online status: net income, net revenue, total assets. The financial report chart shows the values from 31/05/2018 to 28/02/2021. Information on CytoDyn Inc. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
28/02/2021
0 $
-
-43 985 000 $
-
30/11/2020
0 $
-
-34 966 000 $
-
31/08/2020
0 $
-
-30 832 000 $
-
31/05/2020
0 $
-
-57 611 206 $
-
30/11/2019
0 $
-
-14 860 468 $
-
31/08/2019
0 $
-
-16 163 999 $
-
31/05/2019
0 $
-
-14 893 899 $
-
28/02/2019
0 $
-
-12 573 811 $
-
30/11/2018
0 $
-
-14 305 380 $
-
31/08/2018
0 $
-
-14 413 569 $
-
31/05/2018
0 $
-
-9 623 623 $
-
Show:
to
CytoDyn Inc. financial report charts
The dates of the latest financial statements of CytoDyn Inc.: 31/05/2018, 30/11/2020, 28/02/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of CytoDyn Inc. is available online for such a date - 28/02/2021. Operating income CytoDyn Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income CytoDyn Inc. is -20 736 000 $
CytoDyn Inc. quarterly report dates
Net income CytoDyn Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income CytoDyn Inc. is -43 985 000 $ Current assets CytoDyn Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets CytoDyn Inc. is 110 855 000 $ Total assets CytoDyn Inc. refers to the total amount of assets owned by a person or entity. Total assets CytoDyn Inc. is 113 654 000 $
Current cash CytoDyn Inc. - the sum of all of the cash a company has on the date of report. Current cash CytoDyn Inc. is 14 291 000 $
28/02/2021
30/11/2020
31/08/2020
31/05/2020
30/11/2019
31/08/2019
31/05/2019
28/02/2019
30/11/2018
31/08/2018
31/05/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-20 736 000 $
-24 503 000 $
-25 568 000 $
-27 819 492 $
-12 120 752 $
-12 632 297 $
-13 804 244 $
-12 871 324 $
-15 687 790 $
-13 488 693 $
-11 196 755 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-43 985 000 $
-34 966 000 $
-30 832 000 $
-57 611 206 $
-14 860 468 $
-16 163 999 $
-14 893 899 $
-12 573 811 $
-14 305 380 $
-14 413 569 $
-9 623 623 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
12 323 000 $
16 446 000 $
15 188 000 $
19 949 281 $
8 526 398 $
9 055 289 $
9 195 373 $
9 022 223 $
12 869 244 $
11 403 294 $
8 920 772 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
20 736 000 $
24 503 000 $
25 568 000 $
27 819 492 $
12 120 752 $
12 632 297 $
13 804 244 $
12 871 324 $
15 687 790 $
13 488 693 $
11 196 755 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
110 855 000 $
130 794 000 $
79 876 000 $
36 827 032 $
3 245 151 $
3 199 998 $
5 369 420 $
4 467 471 $
3 927 875 $
7 539 780 $
3 320 627 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
113 654 000 $
143 762 000 $
93 362 000 $
50 514 135 $
17 916 972 $
18 386 653 $
20 874 125 $
20 427 545 $
20 390 953 $
9 031 442 $
4 898 998 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
14 291 000 $
29 407 000 $
18 200 000 $
14 281 830 $
409 452 $
1 795 822 $
2 612 910 $
1 593 629 $
772 361 $
4 749 413 $
1 231 445 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
29 702 044 $
23 066 607 $
26 926 348 $
22 258 925 $
23 982 761 $
24 139 175 $
16 733 237 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
31 548 569 $
25 181 248 $
29 788 185 $
26 676 584 $
28 454 877 $
28 828 746 $
18 056 969 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
176.08 %
136.95 %
142.70 %
130.59 %
139.55 %
319.20 %
368.58 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-15 795 000 $
-6 534 000 $
2 768 000 $
-2 480 586 $
-13 631 697 $
-6 794 692 $
-8 914 155 $
-6 249 131 $
-8 064 016 $
-19 797 396 $
-13 158 063 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-6 784 524 $
-15 190 397 $
-9 512 371 $
-14 760 804 $
-17 222 329 $
-8 970 660 $
-6 978 980 $
Last revenue report of CytoDyn Inc. was 28/02/2021. According to last financial report total revenue in CytoDyn Inc. was 0 US dollar and changed by 0% since last year. Net income in CytoDyn Inc. was -43 985 000 $ in last quartal, net income changes to 0%.
